Proteasome — Drug Target

All drugs that target Proteasome — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Proteasome inhibitor · Proteasome inhibitor and corticosteroid combination

Phase 3 pipeline (3)

• VELCADE Administered by subcutaneous injection · Millennium Pharmaceuticals, Inc. · Proteasome inhibitor · Oncology
  VELCADE is a proteasome inhibitor that blocks the action of proteasomes in cells, leading to cell death.
• Velcade-Dexamethasone · Intergroupe Francophone du Myelome · Proteasome inhibitor and corticosteroid combination · Oncology
  Velcade-Dexamethasone is a combination of a proteasome inhibitor and a corticosteroid used to treat multiple myeloma.
• Velcade, Thalidomide, Dexamethasone · University of Arkansas · Proteasome inhibitor · Oncology
  Velcade (bortezomib) is a proteasome inhibitor that blocks the action of proteasomes, which are complexes that break down proteins in cells.